MELISSA BETHANY: Open Payments
NPI 1770943086 · ROSWELL, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 29 payments from 12 companies in 2025. Trend: 2023 $238 · 2024 $451 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $140 |
| Alkermes, Inc. | 4 | $80 |
| ABBVIE INC. | 3 | $57 |
| Lundbeck LLC | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| HARMONY BIOSCIENCES LLC | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: Auvelity, REXULTI, ARISTADA, VRAYLAR, WAKIX, COBENFY, Qelbree, AUSTEDO XR.
Industry payments across NM — which companies pay providers there.
